Literature DB >> 16978814

Cell death after co-administration of cisplatin and ethacrynic acid.

Dalian Ding1, Haiyan Jiang, Ping Wang, Richard Salvi.   

Abstract

Ethacrynic acid (EA) significantly enhances the ototoxic effects of cisplatin. To gain insights into the mechanisms underlying Cis/EA ototoxicity, cochleas were labeled with several apoptotic markers. Cis/EA treatment caused extensive outer hair cell (OHC) and inner hair cell (IHC) damage; OHC lesions decreased from the base towards apex of the cochlea whereas the IHC lesion was relatively constant (25-60%) along the length of the cochlea. Propidium iodide labeled OHC nuclei appeared relatively normal at 6h post-treatment, were condensed and fragmented at 12h post-treatment and were frequently missing 48 h post-treatment. Initiator caspase 8, associated with membrane death receptors, and TRADD, a protein that recruits caspase 8, were present in OHC at 6h post-treatment. Caspase 8 labeling increased from 6 to 24h, but was largely absent at 48 h post-treatment. Executioner caspase 3 and caspase 6, which lie downstream of caspase 8, were expressed in OHC 12-24h post-treatment. Initiator caspase 9, associated with mitochondrial damage, was only expressed at low levels at 48 h post-treatment. These results suggest that the rapid onset of Cis/EA induced programmed cell death is initiated by membrane death receptors associated with TRADD and caspase 8.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16978814     DOI: 10.1016/j.heares.2006.07.015

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  25 in total

1.  Salicylate-induced degeneration of cochlea spiral ganglion neurons-apoptosis signaling.

Authors:  L Wei; D Ding; R Salvi
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

2.  Cobalt-Induced Ototoxicity in Rat Postnatal Cochlear Organotypic Cultures.

Authors:  Peng Li; Dalian Ding; Richard Salvi; Jerome A Roth
Journal:  Neurotox Res       Date:  2015-07-08       Impact factor: 3.911

3.  Comparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide.

Authors:  Li Xia; Zhengnong Chen; Kaiming Su; Shankai Yin; Jian Wang
Journal:  Toxicol Pathol       Date:  2013-04-02       Impact factor: 1.902

4.  Ototoxic destruction by co-administration of kanamycin and ethacrynic acid in rats.

Authors:  Hong Liu; Da-lian Ding; Hai-yan Jiang; Xue-wen Wu; Richard Salvi; Hong Sun
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

5.  Some Ototoxic Drugs Destroy Cochlear Support Cells Before Damaging Sensory Hair Cells.

Authors:  Dalian Ding; Jianhui Zhang; Haiyan Jiang; Weijun Xuan; Weidong Qi; Richard Salvi
Journal:  Neurotox Res       Date:  2020-01-29       Impact factor: 3.911

6.  Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.

Authors:  Yongqi Li; Dalian Ding; Haiyan Jiang; Yong Fu; Richard Salvi
Journal:  Neurotox Res       Date:  2011-04-01       Impact factor: 3.911

7.  Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis.

Authors:  Shinichi Someya; Jinze Xu; Kenji Kondo; Dalian Ding; Richard J Salvi; Tatsuya Yamasoba; Peter S Rabinovitch; Richard Weindruch; Christiaan Leeuwenburgh; Masaru Tanokura; Tomas A Prolla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures.

Authors:  Weidong Qi; Dalian Ding; Richard J Salvi
Journal:  Hear Res       Date:  2007-12-15       Impact factor: 3.208

9.  Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid.

Authors:  Dalian Ding; Haiyan Jiang; Richard J Salvi
Journal:  Hear Res       Date:  2009-08-26       Impact factor: 3.208

Review 10.  Ototoxicity of Divalent Metals.

Authors:  Jerome A Roth; Richard Salvi
Journal:  Neurotox Res       Date:  2016-05-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.